Land: Storbritannien
Sprog: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Hydrocortisone
Genesis Pharmaceuticals Ltd
H02AB09
Hydrocortisone
10mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 06030200; GTIN: 5060014444370
Package leaflet: Information for the user Hydrocortisone 10mg Soluble Tablets Hydrocortisone Important things you need to know about Hydrocortisone ■ Hydrocortisone is a steroid medicine, prescribed for many different conditions, including replacement therapy, emergency treatment of asthma, the treatment of drug reactions, serum sickness and severe allergic reactions in adults and children. ■ You will need to take it as prescribed, to get the maximum benefit. ■ Do not stop taking this medicine without first talking to your doctor - you may need to reduce the dose gradually. ■ Hydrocortisone can cause side effects in some people (read section 4 below). Some side effects may happen straight away. If you feel unwell in any way, see your doctor as soon as possible. ■ Some side effects only happen after weeks or months. (Read section 4 below for more information). ■ If you take this medicine for more than 3 weeks, you will get a blue ‘Steroid Treatment Card’: always keep this with you and show it to any doctor or nurse treating you. ■ Keep away from people who have chicken-pox or shingles, if you have never had them. They could affect you severely. If you do come into contact with chicken-pox or shingles, consult your doctor straight away. Now read the rest of this leaflet. It includes other important information on the safe and effective use of this medicine that may be especially important for you. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. ■ Keep this leaflet. You may need to read it again. ■ If you have any further questions, ask your doctor or pharmacist or nurse. ■ This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. ■ If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. ■ The name of this medicine is Hydrocorti Læs hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Hydrocortisone 10mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Hydrocortisone 10mg Excipients: Hydrocortisone 10mg Tablets contain 64.3mg lactose monohydrate per tablet. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablets. Round, white tablet, with ‘H10’ imprinted on one side and a breakline on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Corticosteroid. For use as replacement therapy in primary, secondary, or acute adrenocortical insufficiency. Pre-operatively, and during serious trauma or illness in patients with known adrenal insufficiency or doubtful adrenocortical reserve. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Dosage must be individualised according to the response of the individual patient. The lowest possible dosage should be used. Doses should be multiples of 10 (ie 10mg, 20mg, 30mg, etc). Patients should be observed closely for signs that might require dosage adjustment, including changes in clinical status resulting from remissions or exacerbations of the disease, individual drug responsiveness, and the effect of stress (eg surgery, infection, trauma). During stress it may be necessary to increase the dosage temporarily. To avoid hypoadrenalism and/or a relapse of the underlying disease, it may be necessary to withdraw the drug gradually (see 4.4 'Special warnings and precautions for use'). In chronic adrenocortical insufficiency, a dosage of 20 to 30mg a day is usually recommended, sometimes together with 4-6g of sodium chloride or 50-300micrograms of fludrocortisone daily. When immediate support is mandatory, one of the soluble adrenocortical hormone preparations (eg dexamethasone sodium phosphate), which may be effective within minutes after parenteral administration, can be life-saving. _Use _ _in _ _children_: In chronic adrenocortical insufficiency, the dosage should be approximately 0.4 to 0.8mg/kg/day in two or three divided doses, adjusted to the needs of the individual Læs hele dokumentet